Glucose-dependent insulinotropic polypeptide in diabetes and obesity / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
; (12): 735-738, 2015.
Article
en Zh
| WPRIM
| ID: wpr-476573
Biblioteca responsable:
WPRO
ABSTRACT
[Summary] Glucose-dependent insulinotropic polypeptide ( GIP) is known to promote the release of insulin fromβcells, but this function suffers from a defect in obese patients. More and more evidences suggest that GIP is the bridge between a high-fat diet, obesity, insulin resistance, and type 2 diabetes. With the deepening of research in GIP in type 2 diabetes and obesity, GIP may provide new ideas for the treatment of type 2 diabetes and obesity.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Endocrinology and Metabolism
Año:
2015
Tipo del documento:
Article